BioSpace News Archive

Drug Development

Chimerix’s Drug Candidate Improves Survival for Patients with Incurable Brain Tumor

The company’s first-in-class small molecule imipridone, ONC201, showed strong efficacy results in two early-stage clinical trials of 71 pediatric patients with H3K27M-mutant diffuse midline gliomas.

August 17, 2023
·
3 min read
·
Matt Olszewski
Policy

Federal Appeals Court Rules for Tighter Restrictions on Abortion Pill

Mifepristone’s legal saga continues as the U.S. 5th Circuit Court of Appeals ruled for steep restrictions on the drug’s access, though its effectivity is pending the Supreme Court’s review.

August 17, 2023
·
2 min read
·
Tristan Manalac
FDA

FDA Approves Ipsen’s Palovarotene for Ultra-Rare Bone Disease

After two prior setbacks, the regulator has finally approved Ipsen’s palovarotene to treat fibrodysplasia ossificans progressiva. It’s the first treatment for the ultra-rare bone disease.

August 17, 2023
·
2 min read
·
Tristan Manalac
Policy

FDA Pilot Program for Cancer Diagnostics Met with Skepticism

Some experts question the value of recently issued FDA guidance that aims to address gaps in the quality of unapproved laboratory tests for cancer.

August 17, 2023
·
5 min read
·
Hayley Shasteen
ATCC Hires New Chief Financial Officer

Scott Boller, CPA, brings more than 25 years of financial and accounting leadership in the tech, software, and pharmaceutical industries to ATCC.

August 17, 2023
·
2 min read
Drug Development

Boehringer Initiates Phase III Obesity Trials, Seeks to Challenge Novo and Lilly

The German company on Thursday said it is launching three late-stage studies of its obesity drug candidate after the injectable showed up to 19% weight loss after 46 weeks in a mid-stage trial.

August 17, 2023
·
2 min read
·
Kate Goodwin
Business

Selecta Biosciences Halts Pipeline Investments, Focuses on Gout Treatment

The company disclosed Thursday in a second-quarter report that it will continue advancing its chronic refractory gout treatment but is suspending further investments in its pipeline.

August 17, 2023
·
2 min read
·
Connor Lynch
Zealand Pharma Announces Financial Results for the First Half of 2023

Zealand Pharma A/S, a biotechnology company focused on the discovery and development of innovative peptide-based medicines, announced the interim report for the six months ended June 30, 2023 and provided a corporate update.

August 17, 2023
·
12 min read
Valneva Announces Extension of Existing Loan Agreement

Valneva SE, a specialty vaccine company, announced an agreement to increase the principal amount of its existing $100 million senior secured debt financing agreement with funds managed by leading U.S. healthcare investment firms Deerfield Management Company and OrbiMed.

August 17, 2023
·
4 min read
Job Trends

Roche launches a new addition to the cobas® connection modules, the CCM Vertical, helping to improve laboratory efficiency

Roche announced that it has a new addition to the cobas® connection modules, the CCM Vertical, allowing transportation of samples on overhead conveyors.* This solution allows for CCM conveyors to cross walkways, connecting different work areas and keeps exits accessible.

August 17, 2023
·
4 min read